robust
oligonucleotid
arrayinwel
hybrid
assay
use
novel
upconvert
phosphor
report
technolog
appli
genotyp
clinic
relev
human
adenoviru
type
total
adenovirusposit
respiratori
ocular
swab
stool
specimen
patient
collect
april
april
includ
studi
realtim
pcr
amplif
target
adenoviru
hexon
gene
arrayinwel
assay
identifi
presenc
n
patient
genotyp
among
clinic
sampl
panel
type
result
obtain
specimen
could
amplifi
n
specif
type
confirm
sequenc
specimen
repres
differ
genotyp
hybrid
signal
obtain
adenovirusneg
specimen
specimen
virus
n
arrayinwel
hybrid
assay
great
potenti
rapid
multiplex
platform
type
clinic
relev
human
adenoviru
genotyp
differ
specimen
type
human
adenovirus
hadv
belong
genu
mastadenoviru
famili
adenovirida
present
differ
hadv
type
group
seven
speci
g
differ
type
caus
wide
rang
acut
chronic
diseas
acut
respiratori
diseas
predominantli
caus
hadv
type
occasion
type
wherea
gastroenter
commonli
associ
type
age
group
hadv
infect
includ
asymptomat
infect
may
provok
seriou
ill
pneumonia
type
epidem
keratoconjunct
type
type
also
caus
sever
outbreak
respiratori
ill
among
militari
recruit
human
adv
caus
especi
sever
diseas
among
infant
young
children
immunocompromis
patient
transplant
recipi
hadv
infect
occur
worldwid
endem
epidem
sporad
infect
therefor
genotypespecif
analysi
import
epidemiolog
studi
provid
inform
incid
distribut
infect
individu
hadv
type
genotyp
identif
also
necessari
detect
new
strain
understand
hadv
pathogenesi
identif
serotyp
tradit
carri
neutral
typespecif
antisera
serolog
detect
method
usual
timeconsum
labourintens
permit
reliabl
detect
hadv
serotyp
avail
rapid
diagnost
method
provid
uncompromis
analyt
perform
would
allow
effici
screen
identif
pathogen
today
genotyp
molecular
method
pcr
target
hexon
fibr
gene
follow
amplicon
sequenc
digest
amplicon
differ
restrict
enzym
often
prefer
serotyp
recent
pcrbase
microspher
array
revers
line
blot
hybrid
method
describ
detect
differenti
hadv
genotyp
anoth
approach
multiplex
detect
microarray
analysi
hold
great
potenti
detect
type
pathogen
microarray
techniqu
flexibl
rapid
suitabl
high
throughput
analysi
sensit
pcr
specif
dna
hybrid
combin
microarray
technolog
use
detect
type
adenovirus
previou
studi
feasibl
upconvert
phosphor
ucp
report
technolog
antistok
photoluminesc
detect
new
antistok
photoluminesc
imag
demonstr
multianalyt
assay
ucp
inorgan
lanthanidedop
crystal
uniqu
capabl
convert
infrar
radiat
visibl
light
via
absorpt
multipl
photon
autofluoresc
produc
biolog
materi
enabl
sensit
assay
show
realtim
pcr
arrayinwel
hybrid
test
platform
could
use
type
hadv
standard
microtitr
plate
present
studi
arrayinwel
type
assay
expand
technic
improv
white
plate
nanos
nm
upconvert
nanoparticl
ucnp
use
instead
transpar
microtitr
well
plate
larger
nm
ucp
particl
exposur
time
white
plate
make
assay
implement
userfriendli
new
forward
primer
realtim
pcr
design
longer
amplicon
variat
sequenc
need
probe
design
new
oligonucleotid
probe
design
type
clinic
relev
member
hadv
group
f
updat
arrayinwel
test
platform
success
identifi
hadv
genotyp
ocular
swab
respiratori
stool
urin
specimen
prototyp
hadv
genotyp
origin
obtain
center
diseas
control
prevent
cdc
atlanta
ga
prototyp
cultiv
hela
cell
cultur
human
cervix
carcinoma
celllin
hela
ohio
common
cold
unit
salisburi
wiltshir
uk
prototyp
cultiv
cell
cultur
human
lung
carcinoma
celllin
american
type
cultur
collect
atcc
rockvil
md
isol
viral
dna
recent
isol
hadv
genotyp
kindli
donat
huslab
helsinki
finland
hela
cell
maintain
eagl
minim
essenti
ham
medium
gibco
invitrogen
carlsbad
ca
respect
co
nasopharyng
aspir
swab
n
ocular
swab
n
stool
n
type
respiratori
specimen
n
other
n
unknown
n
specimen
select
process
clinic
specimen
sent
depart
virolog
univers
turku
hadv
detect
april
april
specimen
test
posit
hadv
use
timeresolv
fluoroimmunoassay
specimen
singl
pcr
multiplex
pcr
detect
seeplex
seegen
seoul
korea
viru
cultur
total
adenovirusneg
specimen
includ
specimen
influenza
b
viru
n
parainfluenza
viru
n
coronaviru
n
varicella
zoster
viru
n
herp
simplex
viru
type
n
rhinoviru
n
enteroviru
n
respiratori
syncyti
viru
n
also
test
evalu
specif
assay
see
supplementari
materi
data
nanocrystallin
nayf
yb
er
materi
crystallit
size
nm
prepar
modif
method
report
earlier
descript
synthesi
surfac
modif
ucnp
found
supplementari
materi
data
procedur
coat
ucnp
streptavidin
describ
earlier
nucleic
acid
extract
specimen
use
nuclisens
easymag
biomerieux
boxtel
netherland
magna
pure
roch
mannheim
germani
autom
extractor
extract
store
asymmetr
realtim
pcr
amplif
reaction
target
hexon
code
region
perform
reaction
mixtur
contain
lm
gener
forward
primer
lm
biotinyl
revers
primer
aliquot
extract
dna
see
supplementari
materi
data
posit
control
type
dna
templat
control
includ
pcr
run
reaction
melt
curv
analysi
carri
use
sybr
green
qpcr
master
mix
fermenta
st
leonrot
germani
rotorgen
instrument
corbett
research
mortlak
victoria
australia
thermal
cycl
consist
initi
denatur
enzym
activ
min
follow
cycl
denatur
anneal
extens
final
melt
curv
gener
step
increment
pcr
product
use
hybrid
assay
sequenc
purifi
quickclean
pcr
purif
kit
genscript
piscataway
nj
elut
volum
nucleasefre
steril
water
amplicon
sequenc
dna
sequenc
servic
laboratori
turku
centr
biotechnolog
turku
finland
use
primer
oligonucleotid
probe
hadv
genotyp
design
use
publish
hexon
sequenc
data
hplcpurifi
oligonucleotid
obtain
http
wwwbiomersnet
ulm
germani
improv
probe
avail
hybrid
oligonucleotid
synthes
three
extra
tc
nucleotid
spacer
end
termin
aminolink
group
probe
use
gener
detect
hadv
data
hadv
genotyp
aim
identifi
least
one
gener
probe
target
genotyp
one
specif
probe
uniqu
pattern
microarray
white
microtitr
plate
nunc
thermo
fisher
scientif
roskild
denmark
prepar
vtt
medic
biotechnolog
centr
turku
finland
hybrid
assay
imag
array
imag
analysi
carri
describ
earlier
briefli
hadv
genotypespecif
probe
spot
print
coval
three
replic
bottom
white
microtitr
plate
oligonucleotid
probe
hybrid
denatur
biotinyl
pcr
product
bound
biotinyl
product
detect
streptavidinco
ucnp
see
supplementari
materi
data
arrayinwel
assay
measur
antistok
photoluminesc
imag
devic
construct
multiplex
test
laser
diod
excit
ccd
imag
sensor
minor
chang
optic
round
diffus
holoor
rechovot
israel
ad
collim
excit
filter
paramet
use
studi
bin
exposur
per
well
w
laser
power
genotyp
call
accord
pattern
fluoresc
probe
spot
combin
one
revers
primer
three
forward
primer
specif
part
conserv
hexon
gene
region
allow
amplif
hadv
genotyp
belong
differ
speci
f
asymmetr
realtim
pcr
amplifi
nucleic
acid
prototyp
use
studi
human
adv
dna
amplifi
clinic
specimen
origin
test
posit
hadv
sensit
realtim
pcr
determin
type
detect
concentr
ten
copi
per
reaction
data
shown
plot
cycl
threshold
c
valu
prototyp
clinic
specimen
shown
fig
adenoviru
neg
clinic
specimen
frequent
show
nonspecif
late
amplif
c
complic
hadv
detect
pcr
method
alon
eleven
differ
hadv
genotyp
identifi
among
hadvposit
clinic
specimen
microarray
pro
fig
crossreact
virus
hadvneg
specimen
n
observ
nontarget
prototyp
show
strong
hybrid
signal
gener
probe
array
abl
discrimin
target
hexon
sequenc
show
sequenc
homolog
five
mismatch
bp
region
two
type
randomli
select
sampl
n
repres
detect
genotyp
sequenc
assur
assay
result
case
genotyp
reveal
microarray
consist
sequenc
result
fever
cold
cough
pharyng
conjunct
commonli
report
clinic
manifest
among
patient
preval
hadv
genotyp
n
specimen
addit
sever
hadv
genotyp
identifi
among
clinic
sampl
panel
n
n
n
n
n
n
n
one
femal
patient
subsequ
infect
genotyp
month
apart
hadv
genotyp
mainli
detect
children
year
age
genotyp
detect
one
immunocompromis
femal
patient
ten
coinfect
specimen
detect
among
sampl
panel
one
boy
coinfect
hadv
genotyp
coxackieviru
detect
stool
nine
coinfect
detect
girl
boy
age
year
respiratori
specimen
hadv
genotyp
rhinoviru
parainfluenza
viru
type
respiratori
syncyti
viru
influenza
viru
b
rhinoviru
influenza
viru
b
respiratori
syncyti
viru
metapneumoviru
metapneumoviru
age
rang
patient
year
median
age
year
male
patient
femal
patient
studi
hadv
infect
preval
adult
patient
age
women
hadv
genotyp
distribut
throughout
age
group
fig
hadv
genotyp
detect
ocular
swab
n
hadv
genotyp
detect
respiratori
np
fig
specimen
n
fig
human
adv
infect
preval
throughout
year
peak
septemb
octob
fig
main
purpos
studi
demonstr
capabl
arrayinwel
hybrid
assay
identifi
hadv
genotyp
preval
patient
finland
studi
period
use
asymmetr
realtim
pcr
produc
amplicon
type
hybrid
assay
use
ucnplabel
obtain
genotyp
result
specimen
develop
arrayinwel
hybrid
assay
broader
type
select
mani
publish
hadv
type
assay
base
hybrid
except
revers
line
blot
hybrid
method
although
hadv
prototyp
avail
vitro
test
silico
analys
gave
specif
pattern
target
genotyp
predict
would
differenti
differenti
anoth
weak
pcr
method
alon
suffici
specif
hadv
detect
howev
assay
attract
advantag
compar
assay
first
hybrid
assay
perform
microtitr
plate
allow
use
common
laboratori
equip
assay
easi
carri
second
microtitr
plate
enabl
analysi
sampl
one
time
necessari
also
possibl
add
probe
microtitr
plate
enabl
type
addit
hadv
genotyp
one
assay
studi
period
outbreak
hadv
type
infect
occur
autumn
type
commonli
associ
conjunct
n
respiratori
diseas
studi
conduct
report
restrict
enzym
analysi
identifi
three
genet
variant
type
includ
two
newli
describ
variant
new
variant
type
could
reason
high
incid
infect
studi
predomin
adenoviru
genotyp
differ
countri
region
chang
time
hadv
type
emerg
signific
contributor
acut
respiratori
diseas
sever
pneumonia
usa
militari
recruit
train
centr
across
usa
rare
identifi
also
emerg
europ
present
studi
neither
indistinguish
current
assay
detect
among
clinic
specimen
studi
multiplex
assay
platform
gener
identifi
common
epidem
hadv
genotyp
develop
arrayinwel
hybrid
assay
specif
probe
offer
rapid
day
sampl
prepar
imag
hybrid
microarray
tool
genotyp
signific
hadv
type
involv
differ
clinic
condit
